APO Research
Talk to an analyst

APO RESEARCH · REPORT

EAAT2 Antibody

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global EAAT2 Antibody Market Outlook and Growth Opportunities 2026

19 December 2025195 pages

Choose your research edition.

Industry ResearchEAAT2 Antibody Industry Research Report 2026125 pages · $2,950 USDIndustry Growth & TrendsGlobal EAAT2 Antibody Industry Growth and Trends Forecast to 2032100 pages · $3,450 USDMarket StructureGlobal EAAT2 Antibody Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032198 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal EAAT2 Antibody Market Outlook and Growth Opportunities 2026195 pages · $4,250 USDMarket Analysis & ForecastGlobal EAAT2 Antibody Market Analysis and Forecast 2026-2032195 pages · $4,950 USD

Market perspective

The global EAAT2 Antibody market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for EAAT2 Antibody is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for EAAT2 Antibody is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for EAAT2 Antibody is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the EAAT2 Antibody market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the EAAT2 Antibody market include Merck, United States Biological, Boster Biological Technology, Proteintech, NSJ Bioreagents, LSBio, GeneTex, FineTest and FabGennix International, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global EAAT2 Antibody market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of EAAT2 Antibody and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents EAAT2 Antibody sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the EAAT2 Antibody market size, projected growth trends, production technologies, key applications, and end-use industries.

EAAT2 Antibody Segment by Company

Merck

United States Biological

Boster Biological Technology

Proteintech

NSJ Bioreagents

LSBio

GeneTex

FineTest

FabGennix International

Creative Biolabs

Cell Signaling Technology

Bioss

Affinity Biosciences

Abcam

EAAT2 Antibody Segment by Type

Polyclonal

Monoclonal

EAAT2 Antibody Segment by Application

Enzyme Linked Immunosorbent Assay

Immunoprecipitation

Immunocytochemistry

Others

EAAT2 Antibody Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global EAAT2 Antibody status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions EAAT2 Antibody market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify EAAT2 Antibody significant trends, drivers, influence factors in global and regions.

6. To analyze EAAT2 Antibody competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global EAAT2 Antibody market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of EAAT2 Antibody and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of EAAT2 Antibody.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the EAAT2 Antibody market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global EAAT2 Antibody industry.

Chapter 3: Detailed analysis of EAAT2 Antibody manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of EAAT2 Antibody in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of EAAT2 Antibody in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. EAAT2 Antibody Industry Trends Table 2. EAAT2 Antibody Industry Drivers Table 3. EAAT2 Antibody Industry Opportunities and Challenges Table 4. EAAT2 Antibody Industry Restraints Table 5. Global EAAT2 Antibody Revenue by Company (US$ Million) & (2021-2026) Table 6. Global EAAT2 Antibody Revenue Share by Company (2021-2026) Table 7. Global EAAT2 Antibody Sales Volume by Company (Kg) & (2021-2026) Table 8. Global EAAT2 Antibody Sales Volume Share by Company (2021-2026) Table 9. Global EAAT2 Antibody Average Price (US$/Kg) of Company (2021-2026) Table 10. Global EAAT2 Antibody Company Ranking, (2024-2026) & (USD Million) Table 11. Global EAAT2 Antibody Key Company Manufacturing Base & Headquarters Table 12. Global EAAT2 Antibody Company, Product Type & Application Table 13. Global EAAT2 Antibody Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global EAAT2 Antibody by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Polyclonal Table 18. Significant Companies of Monoclonal Table 19. Global EAAT2 Antibody Sales Volume by Type 2021 VS 2025 VS 2032 (Kg) Table 20. Global EAAT2 Antibody Sales Volume by Type (2021-2026) & (Kg) Table 21. Global EAAT2 Antibody Sales Volume by Type (2027-2032) & (Kg) Table 22. Global EAAT2 Antibody Sales Volume Share by Type (2021-2026) Table 23. Global EAAT2 Antibody Sales Volume Share by Type (2027-2032) Table 24. Global EAAT2 Antibody Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global EAAT2 Antibody Sales Value by Type (2021-2026) & (US$ Million) Table 26. Global EAAT2 Antibody Sales Value by Type (2027-2032) & (US$ Million) Table 27. Global EAAT2 Antibody Sales Value Share by Type (2021-2026) Table 28. Global EAAT2 Antibody Sales Value Share by Type (2027-2032) Table 29. Significant Companies of Enzyme Linked Immunosorbent Assay Table 30. Significant Companies of Immunoprecipitation Table 31. Significant Companies of Immunocytochemistry Table 32. Significant Companies of Others Table 33. Global EAAT2 Antibody Sales Volume by Application 2021 VS 2025 VS 2032 (Kg) Table 34. Global EAAT2 Antibody Sales Volume by Application (2021-2026) & (Kg) Table 35. Global EAAT2 Antibody Sales Volume by Application (2027-2032) & (Kg) Table 36. Global EAAT2 Antibody Sales Volume Share by Application (2021-2026) Table 37. Global EAAT2 Antibody Sales Volume Share by Application (2027-2032) Table 38. Global EAAT2 Antibody Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 39. Global EAAT2 Antibody Sales Value by Application (2021-2026) & (US$ Million) Table 40. Global EAAT2 Antibody Sales Value by Application (2027-2032) & (US$ Million) Table 41. Global EAAT2 Antibody Sales Value Share by Application (2021-2026) Table 42. Global EAAT2 Antibody Sales Value Share by Application (2027-2032) Table 43. Global EAAT2 Antibody Sales by Region: 2021 VS 2025 VS 2032 (Kg) Table 44. Global EAAT2 Antibody Sales by Region (2021-2026) & (Kg) Table 45. Global EAAT2 Antibody Sales Market Share by Region (2021-2026) Table 46. Global EAAT2 Antibody Sales by Region (2027-2032) & (Kg) Table 47. Global EAAT2 Antibody Sales Market Share by Region (2027-2032) Table 48. Global EAAT2 Antibody Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 49. Global EAAT2 Antibody Sales Value by Region (2021-2026) & (US$ Million) Table 50. Global EAAT2 Antibody Sales Value Share by Region (2021-2026) Table 51. Global EAAT2 Antibody Sales Value by Region (2027-2032) & (US$ Million) Table 52. Global EAAT2 Antibody Sales Value Share by Region (2027-2032) Table 53. Global EAAT2 Antibody Market Average Price (US$/Kg) by Region (2021-2026) Table 54. Global EAAT2 Antibody Market Average Price (US$/Kg) by Region (2027-2032) Table 55. Global EAAT2 Antibody Sales by Country: 2021 VS 2025 VS 2032 (Kg) Table 56. Global EAAT2 Antibody Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 57. Global EAAT2 Antibody Sales by Country (2021-2026) & (Kg) Table 58. Global EAAT2 Antibody Sales Market Share by Country (2021-2026) Table 59. Global EAAT2 Antibody Sales by Country (2027-2032) & (Kg) Table 60. Global EAAT2 Antibody Sales Market Share by Country (2027-2032) Table 61. Global EAAT2 Antibody Sales Value by Country (2021-2026) & (US$ Million) Table 62. Global EAAT2 Antibody Sales Value Market Share by Country (2021-2026) Table 63. Global EAAT2 Antibody Sales Value by Country (2027-2032) & (US$ Million) Table 64. Global EAAT2 Antibody Sales Value Market Share by Country (2027-2032) Table 65. Merck Company Information Table 66. Merck Business Overview Table 67. Merck EAAT2 Antibody Sales (Kg), Value (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 68. Merck EAAT2 Antibody Product Portfolio Table 69. Merck Recent Development Table 70. United States Biological Company Information Table 71. United States Biological Business Overview Table 72. United States Biological EAAT2 Antibody Sales (Kg), Value (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 73. United States Biological EAAT2 Antibody Product Portfolio Table 74. United States Biological Recent Development Table 75. Boster Biological Technology Company Information Table 76. Boster Biological Technology Business Overview Table 77. Boster Biological Technology EAAT2 Antibody Sales (Kg), Value (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 78. Boster Biological Technology EAAT2 Antibody Product Portfolio Table 79. Boster Biological Technology Recent Development Table 80. Proteintech Company Information Table 81. Proteintech Business Overview Table 82. Proteintech EAAT2 Antibody Sales (Kg), Value (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 83. Proteintech EAAT2 Antibody Product Portfolio Table 84. Proteintech Recent Development Table 85. NSJ Bioreagents Company Information Table 86. NSJ Bioreagents Business Overview Table 87. NSJ Bioreagents EAAT2 Antibody Sales (Kg), Value (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 88. NSJ Bioreagents EAAT2 Antibody Product Portfolio Table 89. NSJ Bioreagents Recent Development Table 90. LSBio Company Information Table 91. LSBio Business Overview Table 92. LSBio EAAT2 Antibody Sales (Kg), Value (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 93. LSBio EAAT2 Antibody Product Portfolio Table 94. LSBio Recent Development Table 95. GeneTex Company Information Table 96. GeneTex Business Overview Table 97. GeneTex EAAT2 Antibody Sales (Kg), Value (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 98. GeneTex EAAT2 Antibody Product Portfolio Table 99. GeneTex Recent Development Table 100. FineTest Company Information Table 101. FineTest Business Overview Table 102. FineTest EAAT2 Antibody Sales (Kg), Value (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 103. FineTest EAAT2 Antibody Product Portfolio Table 104. FineTest Recent Development Table 105. FabGennix International Company Information Table 106. FabGennix International Business Overview Table 107. FabGennix International EAAT2 Antibody Sales (Kg), Value (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 108. FabGennix International EAAT2 Antibody Product Portfolio Table 109. FabGennix International Recent Development Table 110. Creative Biolabs Company Information Table 111. Creative Biolabs Business Overview Table 112. Creative Biolabs EAAT2 Antibody Sales (Kg), Value (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 113. Creative Biolabs EAAT2 Antibody Product Portfolio Table 114. Creative Biolabs Recent Development Table 115. Cell Signaling Technology Company Information Table 116. Cell Signaling Technology Business Overview Table 117. Cell Signaling Technology EAAT2 Antibody Sales (Kg), Value (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 118. Cell Signaling Technology EAAT2 Antibody Product Portfolio Table 119. Cell Signaling Technology Recent Development Table 120. Bioss Company Information Table 121. Bioss Business Overview Table 122. Bioss EAAT2 Antibody Sales (Kg), Value (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 123. Bioss EAAT2 Antibody Product Portfolio Table 124. Bioss Recent Development Table 125. Affinity Biosciences Company Information Table 126. Affinity Biosciences Business Overview Table 127. Affinity Biosciences EAAT2 Antibody Sales (Kg), Value (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 128. Affinity Biosciences EAAT2 Antibody Product Portfolio Table 129. Affinity Biosciences Recent Development Table 130. Abcam Company Information Table 131. Abcam Business Overview Table 132. Abcam EAAT2 Antibody Sales (Kg), Value (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 133. Abcam EAAT2 Antibody Product Portfolio Table 134. Abcam Recent Development Table 135. Key Raw Materials Table 136. Raw Materials Key Suppliers Table 137. EAAT2 Antibody Distributors List Table 138. EAAT2 Antibody Customers List Table 139. Research Programs/Design for This Report Table 140. Authors List of This Report Table 141. Secondary Sources Table 142. Primary Sources List of Figures Figure 1. EAAT2 Antibody Product Image Figure 2. Global EAAT2 Antibody Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global EAAT2 Antibody Sales Value (2021-2032) & (US$ Million) Figure 4. Global EAAT2 Antibody Sales (2021-2032) & (Kg) Figure 5. Global EAAT2 Antibody Sales Average Price (US$/Kg) & (2021-2032) Figure 6. Global EAAT2 Antibody Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Polyclonal Image Figure 10. Monoclonal Image Figure 11. Global EAAT2 Antibody Sales Volume by Type (2021 VS 2025 VS 2032) & (Kg) Figure 12. Global EAAT2 Antibody Sales Volume Share 2021 VS 2025 VS 2032 Figure 13. Global EAAT2 Antibody Sales Volume Share by Type (2021-2032) Figure 14. Global EAAT2 Antibody Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 15. Global EAAT2 Antibody Sales Value Share 2021 VS 2025 VS 2032 Figure 16. Global EAAT2 Antibody Sales Value Share by Type (2021-2032) Figure 17. Enzyme Linked Immunosorbent Assay Image Figure 18. Immunoprecipitation Image Figure 19. Immunocytochemistry Image Figure 20. Others Image Figure 21. Global EAAT2 Antibody Sales Volume by Application (2021 VS 2025 VS 2032) & (Kg) Figure 22. Global EAAT2 Antibody Sales Volume Share 2021 VS 2025 VS 2032 Figure 23. Global EAAT2 Antibody Sales Volume Share by Application (2021-2032) Figure 24. Global EAAT2 Antibody Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 25. Global EAAT2 Antibody Sales Value Share 2021 VS 2025 VS 2032 Figure 26. Global EAAT2 Antibody Sales Value Share by Application (2021-2032) Figure 27. Global EAAT2 Antibody Sales by Region: 2021 VS 2025 VS 2032 (Kg) Figure 28. Global EAAT2 Antibody Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 29. Global EAAT2 Antibody Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 30. Global EAAT2 Antibody Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 31. North America EAAT2 Antibody Sales Value (2021-2032) & (US$ Million) Figure 32. North America EAAT2 Antibody Sales Value Share by Country (%), 2025 VS 2032 Figure 33. Europe EAAT2 Antibody Sales Value (2021-2032) & (US$ Million) Figure 34. Europe EAAT2 Antibody Sales Value Share by Country (%), 2025 VS 2032 Figure 35. Asia-Pacific EAAT2 Antibody Sales Value (2021-2032) & (US$ Million) Figure 36. Asia-Pacific EAAT2 Antibody Sales Value Share by Country (%), 2025 VS 2032 Figure 37. South America EAAT2 Antibody Sales Value (2021-2032) & (US$ Million) Figure 38. South America EAAT2 Antibody Sales Value Share by Country (%), 2025 VS 2032 Figure 39. Middle East & Africa EAAT2 Antibody Sales Value (2021-2032) & (US$ Million) Figure 40. Middle East & Africa EAAT2 Antibody Sales Value Share by Country (%), 2025 VS 2032 Figure 41. USA EAAT2 Antibody Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 42. USA EAAT2 Antibody Sales Value Share by Type, 2025 VS 2032 & (%) Figure 43. USA EAAT2 Antibody Sales Value Share by Application, 2025 VS 2032 & (%) Figure 44. Canada EAAT2 Antibody Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 45. Canada EAAT2 Antibody Sales Value Share by Type, 2025 VS 2032 & (%) Figure 46. Canada EAAT2 Antibody Sales Value Share by Application, 2025 VS 2032 & (%) Figure 47. Mexico EAAT2 Antibody Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 48. Mexico EAAT2 Antibody Sales Value Share by Type, 2025 VS 2032 & (%) Figure 49. Mexico EAAT2 Antibody Sales Value Share by Application, 2025 VS 2032 & (%) Figure 50. Germany EAAT2 Antibody Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 51. Germany EAAT2 Antibody Sales Value Share by Type, 2025 VS 2032 & (%) Figure 52. Germany EAAT2 Antibody Sales Value Share by Application, 2025 VS 2032 & (%) Figure 53. France EAAT2 Antibody Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 54. France EAAT2 Antibody Sales Value Share by Type, 2025 VS 2032 & (%) Figure 55. France EAAT2 Antibody Sales Value Share by Application, 2025 VS 2032 & (%) Figure 56. U.K. EAAT2 Antibody Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 57. U.K. EAAT2 Antibody Sales Value Share by Type, 2025 VS 2032 & (%) Figure 58. U.K. EAAT2 Antibody Sales Value Share by Application, 2025 VS 2032 & (%) Figure 59. Italy EAAT2 Antibody Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 60. Italy EAAT2 Antibody Sales Value Share by Type, 2025 VS 2032 & (%) Figure 61. Italy EAAT2 Antibody Sales Value Share by Application, 2025 VS 2032 & (%) Figure 62. Spain EAAT2 Antibody Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 63. Spain EAAT2 Antibody Sales Value Share by Type, 2025 VS 2032 & (%) Figure 64. Spain EAAT2 Antibody Sales Value Share by Application, 2025 VS 2032 & (%) Figure 65. Russia EAAT2 Antibody Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 66. Russia EAAT2 Antibody Sales Value Share by Type, 2025 VS 2032 & (%) Figure 67. Russia EAAT2 Antibody Sales Value Share by Application, 2025 VS 2032 & (%) Figure 68. Netherlands EAAT2 Antibody Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 69. Netherlands EAAT2 Antibody Sales Value Share by Type, 2025 VS 2032 & (%) Figure 70. Netherlands EAAT2 Antibody Sales Value Share by Application, 2025 VS 2032 & (%) Figure 71. Nordic Countries EAAT2 Antibody Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 72. Nordic Countries EAAT2 Antibody Sales Value Share by Type, 2025 VS 2032 & (%) Figure 73. Nordic Countries EAAT2 Antibody Sales Value Share by Application, 2025 VS 2032 & (%) Figure 74. China EAAT2 Antibody Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 75. China EAAT2 Antibody Sales Value Share by Type, 2025 VS 2032 & (%) Figure 76. China EAAT2 Antibody Sales Value Share by Application, 2025 VS 2032 & (%) Figure 77. Japan EAAT2 Antibody Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 78. Japan EAAT2 Antibody Sales Value Share by Type, 2025 VS 2032 & (%) Figure 79. Japan EAAT2 Antibody Sales Value Share by Application, 2025 VS 2032 & (%) Figure 80. South Korea EAAT2 Antibody Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 81. South Korea EAAT2 Antibody Sales Value Share by Type, 2025 VS 2032 & (%) Figure 82. South Korea EAAT2 Antibody Sales Value Share by Application, 2025 VS 2032 & (%) Figure 83. India EAAT2 Antibody Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 84. India EAAT2 Antibody Sales Value Share by Type, 2025 VS 2032 & (%) Figure 85. India EAAT2 Antibody Sales Value Share by Application, 2025 VS 2032 & (%) Figure 86. Australia EAAT2 Antibody Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 87. Australia EAAT2 Antibody Sales Value Share by Type, 2025 VS 2032 & (%) Figure 88. Australia EAAT2 Antibody Sales Value Share by Application, 2025 VS 2032 & (%) Figure 89. Southeast Asia EAAT2 Antibody Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 90. Southeast Asia EAAT2 Antibody Sales Value Share by Type, 2025 VS 2032 & (%) Figure 91. Southeast Asia EAAT2 Antibody Sales Value Share by Application, 2025 VS 2032 & (%) Figure 92. Brazil EAAT2 Antibody Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 93. Brazil EAAT2 Antibody Sales Value Share by Type, 2025 VS 2032 & (%) Figure 94. Brazil EAAT2 Antibody Sales Value Share by Application, 2025 VS 2032 & (%) Figure 95. Argentina EAAT2 Antibody Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 96. Argentina EAAT2 Antibody Sales Value Share by Type, 2025 VS 2032 & (%) Figure 97. Argentina EAAT2 Antibody Sales Value Share by Application, 2025 VS 2032 & (%) Figure 98. Chile EAAT2 Antibody Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 99. Chile EAAT2 Antibody Sales Value Share by Type, 2025 VS 2032 & (%) Figure 100. Chile EAAT2 Antibody Sales Value Share by Application, 2025 VS 2032 & (%) Figure 101. Colombia EAAT2 Antibody Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 102. Colombia EAAT2 Antibody Sales Value Share by Type, 2025 VS 2032 & (%) Figure 103. Colombia EAAT2 Antibody Sales Value Share by Application, 2025 VS 2032 & (%) Figure 104. Peru EAAT2 Antibody Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 105. Peru EAAT2 Antibody Sales Value Share by Type, 2025 VS 2032 & (%) Figure 106. Peru EAAT2 Antibody Sales Value Share by Application, 2025 VS 2032 & (%) Figure 107. Saudi Arabia EAAT2 Antibody Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 108. Saudi Arabia EAAT2 Antibody Sales Value Share by Type, 2025 VS 2032 & (%) Figure 109. Saudi Arabia EAAT2 Antibody Sales Value Share by Application, 2025 VS 2032 & (%) Figure 110. Israel EAAT2 Antibody Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 111. Israel Arabia EAAT2 Antibody Sales Value Share by Type, 2025 VS 2032 & (%) Figure 112. Israel Arabia EAAT2 Antibody Sales Value Share by Application, 2025 VS 2032 & (%) Figure 113. UAE EAAT2 Antibody Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 114. UAE EAAT2 Antibody Sales Value Share by Type, 2025 VS 2032 & (%) Figure 115. UAE EAAT2 Antibody Sales Value Share by Application, 2025 VS 2032 & (%) Figure 116. Turkey EAAT2 Antibody Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 117. Turkey EAAT2 Antibody Sales Value Share by Type, 2025 VS 2032 & (%) Figure 118. Turkey EAAT2 Antibody Sales Value Share by Application, 2025 VS 2032 & (%) Figure 119. Iran EAAT2 Antibody Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 120. Iran EAAT2 Antibody Sales Value Share by Type, 2025 VS 2032 & (%) Figure 121. Iran EAAT2 Antibody Sales Value Share by Application, 2025 VS 2032 & (%) Figure 122. Egypt EAAT2 Antibody Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 123. Egypt EAAT2 Antibody Sales Value Share by Type, 2025 VS 2032 & (%) Figure 124. Egypt EAAT2 Antibody Sales Value Share by Application, 2025 VS 2032 & (%) Figure 125. EAAT2 Antibody Value Chain Figure 126. Manufacturing Cost Structure Figure 127. EAAT2 Antibody Sales Mode & Process Figure 128. Direct Comparison with Distribution Share Figure 129. Distributors Profiles Figure 130. Years Considered Figure 131. Research Process Figure 132. Key Executives Interviewed

Scope & coverage.

Types
  • Polyclonal
  • Monoclonal
Applications
  • Enzyme Linked Immunosorbent Assay
  • Immunoprecipitation
  • Immunocytochemistry
  • Others
Companies covered
  • Merck
  • United States Biological
  • Boster Biological Technology
  • Proteintech
  • NSJ Bioreagents
  • LSBio
  • GeneTex
  • FineTest
  • FabGennix International
  • Creative Biolabs
  • Cell Signaling Technology
  • Bioss
  • Affinity Biosciences
  • Abcam

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global EAAT2 Antibody Sales Value (2021-2032)
  4. 1.2.2 Global EAAT2 Antibody Sales Volume (2021-2032)
  5. 1.2.3 Global EAAT2 Antibody Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 EAAT2 Antibody Market Dynamics
  1. 2.1 EAAT2 Antibody Industry Trends
  2. 2.2 EAAT2 Antibody Industry Drivers
  3. 2.3 EAAT2 Antibody Industry Opportunities and Challenges
  4. 2.4 EAAT2 Antibody Industry Restraints
3 EAAT2 Antibody Market by Company
  1. 3.1 Global EAAT2 Antibody Company Revenue Ranking in 2025
  2. 3.2 Global EAAT2 Antibody Revenue by Company (2021-2026)
  3. 3.3 Global EAAT2 Antibody Sales Volume by Company (2021-2026)
  4. 3.4 Global EAAT2 Antibody Average Price by Company (2021-2026)
  5. 3.5 Global EAAT2 Antibody Company Ranking (2024-2026)
  6. 3.6 Global EAAT2 Antibody Company Manufacturing Base and Headquarters
  7. 3.7 Global EAAT2 Antibody Company Product Type and Application
  8. 3.8 Global EAAT2 Antibody Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global EAAT2 Antibody Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 EAAT2 Antibody Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 EAAT2 Antibody Market by Type
  1. 4.1 EAAT2 Antibody Type Introduction
  2. 4.1.1 Polyclonal
  3. 4.1.2 Monoclonal
  4. 4.2 Global EAAT2 Antibody Sales Volume by Type
  5. 4.2.1 Global EAAT2 Antibody Sales Volume by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global EAAT2 Antibody Sales Volume by Type (2021-2032)
  7. 4.2.3 Global EAAT2 Antibody Sales Volume Share by Type (2021-2032)
  8. 4.3 Global EAAT2 Antibody Sales Value by Type
  9. 4.3.1 Global EAAT2 Antibody Sales Value by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global EAAT2 Antibody Sales Value by Type (2021-2032)
  11. 4.3.3 Global EAAT2 Antibody Sales Value Share by Type (2021-2032)
5 EAAT2 Antibody Market by Application
  1. 5.1 EAAT2 Antibody Application Introduction
  2. 5.1.1 Enzyme Linked Immunosorbent Assay
  3. 5.1.2 Immunoprecipitation
  4. 5.1.3 Immunocytochemistry
  5. 5.1.4 Others
  6. 5.2 Global EAAT2 Antibody Sales Volume by Application
  7. 5.2.1 Global EAAT2 Antibody Sales Volume by Application (2021 VS 2025 VS 2032)
  8. 5.2.2 Global EAAT2 Antibody Sales Volume by Application (2021-2032)
  9. 5.2.3 Global EAAT2 Antibody Sales Volume Share by Application (2021-2032)
  10. 5.3 Global EAAT2 Antibody Sales Value by Application
  11. 5.3.1 Global EAAT2 Antibody Sales Value by Application (2021 VS 2025 VS 2032)
  12. 5.3.2 Global EAAT2 Antibody Sales Value by Application (2021-2032)
  13. 5.3.3 Global EAAT2 Antibody Sales Value Share by Application (2021-2032)
6 EAAT2 Antibody Regional Sales and Value Analysis
  1. 6.1 Global EAAT2 Antibody Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global EAAT2 Antibody Sales by Region (2021-2032)
  3. 6.2.1 Global EAAT2 Antibody Sales by Region: 2021-2026
  4. 6.2.2 Global EAAT2 Antibody Sales by Region (2027-2032)
  5. 6.3 Global EAAT2 Antibody Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global EAAT2 Antibody Sales Value by Region (2021-2032)
  7. 6.4.1 Global EAAT2 Antibody Sales Value by Region: 2021-2026
  8. 6.4.2 Global EAAT2 Antibody Sales Value by Region (2027-2032)
  9. 6.5 Global EAAT2 Antibody Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America EAAT2 Antibody Sales Value (2021-2032)
  12. 6.6.2 North America EAAT2 Antibody Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe EAAT2 Antibody Sales Value (2021-2032)
  15. 6.7.2 Europe EAAT2 Antibody Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific EAAT2 Antibody Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific EAAT2 Antibody Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America EAAT2 Antibody Sales Value (2021-2032)
  21. 6.9.2 South America EAAT2 Antibody Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa EAAT2 Antibody Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa EAAT2 Antibody Sales Value Share by Country, 2025 VS 2032
7 EAAT2 Antibody Country-level Sales and Value Analysis
  1. 7.1 Global EAAT2 Antibody Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global EAAT2 Antibody Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global EAAT2 Antibody Sales by Country (2021-2032)
  4. 7.3.1 Global EAAT2 Antibody Sales by Country (2021-2026)
  5. 7.3.2 Global EAAT2 Antibody Sales by Country (2027-2032)
  6. 7.4 Global EAAT2 Antibody Sales Value by Country (2021-2032)
  7. 7.4.1 Global EAAT2 Antibody Sales Value by Country (2021-2026)
  8. 7.4.2 Global EAAT2 Antibody Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA EAAT2 Antibody Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA EAAT2 Antibody Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA EAAT2 Antibody Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada EAAT2 Antibody Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada EAAT2 Antibody Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada EAAT2 Antibody Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico EAAT2 Antibody Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico EAAT2 Antibody Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico EAAT2 Antibody Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany EAAT2 Antibody Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany EAAT2 Antibody Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany EAAT2 Antibody Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France EAAT2 Antibody Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France EAAT2 Antibody Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France EAAT2 Antibody Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. EAAT2 Antibody Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. EAAT2 Antibody Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. EAAT2 Antibody Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy EAAT2 Antibody Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy EAAT2 Antibody Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy EAAT2 Antibody Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain EAAT2 Antibody Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain EAAT2 Antibody Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain EAAT2 Antibody Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia EAAT2 Antibody Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia EAAT2 Antibody Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia EAAT2 Antibody Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands EAAT2 Antibody Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands EAAT2 Antibody Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands EAAT2 Antibody Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries EAAT2 Antibody Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries EAAT2 Antibody Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries EAAT2 Antibody Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China EAAT2 Antibody Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China EAAT2 Antibody Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China EAAT2 Antibody Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan EAAT2 Antibody Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan EAAT2 Antibody Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan EAAT2 Antibody Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea EAAT2 Antibody Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea EAAT2 Antibody Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea EAAT2 Antibody Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India EAAT2 Antibody Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India EAAT2 Antibody Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India EAAT2 Antibody Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia EAAT2 Antibody Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia EAAT2 Antibody Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia EAAT2 Antibody Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia EAAT2 Antibody Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia EAAT2 Antibody Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia EAAT2 Antibody Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil EAAT2 Antibody Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil EAAT2 Antibody Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil EAAT2 Antibody Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina EAAT2 Antibody Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina EAAT2 Antibody Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina EAAT2 Antibody Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile EAAT2 Antibody Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile EAAT2 Antibody Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile EAAT2 Antibody Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia EAAT2 Antibody Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia EAAT2 Antibody Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia EAAT2 Antibody Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru EAAT2 Antibody Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru EAAT2 Antibody Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru EAAT2 Antibody Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia EAAT2 Antibody Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia EAAT2 Antibody Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia EAAT2 Antibody Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel EAAT2 Antibody Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel EAAT2 Antibody Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel EAAT2 Antibody Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE EAAT2 Antibody Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE EAAT2 Antibody Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE EAAT2 Antibody Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey EAAT2 Antibody Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey EAAT2 Antibody Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey EAAT2 Antibody Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran EAAT2 Antibody Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran EAAT2 Antibody Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran EAAT2 Antibody Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt EAAT2 Antibody Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt EAAT2 Antibody Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt EAAT2 Antibody Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Merck
  2. 8.1.1 Merck Company Information
  3. 8.1.2 Merck Business Overview
  4. 8.1.3 Merck EAAT2 Antibody Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Merck EAAT2 Antibody Product Portfolio
  6. 8.1.5 Merck Recent Developments
  7. 8.2 United States Biological
  8. 8.2.1 United States Biological Company Information
  9. 8.2.2 United States Biological Business Overview
  10. 8.2.3 United States Biological EAAT2 Antibody Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 United States Biological EAAT2 Antibody Product Portfolio
  12. 8.2.5 United States Biological Recent Developments
  13. 8.3 Boster Biological Technology
  14. 8.3.1 Boster Biological Technology Company Information
  15. 8.3.2 Boster Biological Technology Business Overview
  16. 8.3.3 Boster Biological Technology EAAT2 Antibody Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Boster Biological Technology EAAT2 Antibody Product Portfolio
  18. 8.3.5 Boster Biological Technology Recent Developments
  19. 8.4 Proteintech
  20. 8.4.1 Proteintech Company Information
  21. 8.4.2 Proteintech Business Overview
  22. 8.4.3 Proteintech EAAT2 Antibody Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Proteintech EAAT2 Antibody Product Portfolio
  24. 8.4.5 Proteintech Recent Developments
  25. 8.5 NSJ Bioreagents
  26. 8.5.1 NSJ Bioreagents Company Information
  27. 8.5.2 NSJ Bioreagents Business Overview
  28. 8.5.3 NSJ Bioreagents EAAT2 Antibody Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 NSJ Bioreagents EAAT2 Antibody Product Portfolio
  30. 8.5.5 NSJ Bioreagents Recent Developments
  31. 8.6 LSBio
  32. 8.6.1 LSBio Company Information
  33. 8.6.2 LSBio Business Overview
  34. 8.6.3 LSBio EAAT2 Antibody Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 LSBio EAAT2 Antibody Product Portfolio
  36. 8.6.5 LSBio Recent Developments
  37. 8.7 GeneTex
  38. 8.7.1 GeneTex Company Information
  39. 8.7.2 GeneTex Business Overview
  40. 8.7.3 GeneTex EAAT2 Antibody Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 GeneTex EAAT2 Antibody Product Portfolio
  42. 8.7.5 GeneTex Recent Developments
  43. 8.8 FineTest
  44. 8.8.1 FineTest Company Information
  45. 8.8.2 FineTest Business Overview
  46. 8.8.3 FineTest EAAT2 Antibody Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 FineTest EAAT2 Antibody Product Portfolio
  48. 8.8.5 FineTest Recent Developments
  49. 8.9 FabGennix International
  50. 8.9.1 FabGennix International Company Information
  51. 8.9.2 FabGennix International Business Overview
  52. 8.9.3 FabGennix International EAAT2 Antibody Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 FabGennix International EAAT2 Antibody Product Portfolio
  54. 8.9.5 FabGennix International Recent Developments
  55. 8.10 Creative Biolabs
  56. 8.10.1 Creative Biolabs Company Information
  57. 8.10.2 Creative Biolabs Business Overview
  58. 8.10.3 Creative Biolabs EAAT2 Antibody Sales, Value and Gross Margin (2021-2026)
  59. 8.10.4 Creative Biolabs EAAT2 Antibody Product Portfolio
  60. 8.10.5 Creative Biolabs Recent Developments
  61. 8.11 Cell Signaling Technology
  62. 8.11.1 Cell Signaling Technology Company Information
  63. 8.11.2 Cell Signaling Technology Business Overview
  64. 8.11.3 Cell Signaling Technology EAAT2 Antibody Sales, Value and Gross Margin (2021-2026)
  65. 8.11.4 Cell Signaling Technology EAAT2 Antibody Product Portfolio
  66. 8.11.5 Cell Signaling Technology Recent Developments
  67. 8.12 Bioss
  68. 8.12.1 Bioss Company Information
  69. 8.12.2 Bioss Business Overview
  70. 8.12.3 Bioss EAAT2 Antibody Sales, Value and Gross Margin (2021-2026)
  71. 8.12.4 Bioss EAAT2 Antibody Product Portfolio
  72. 8.12.5 Bioss Recent Developments
  73. 8.13 Affinity Biosciences
  74. 8.13.1 Affinity Biosciences Company Information
  75. 8.13.2 Affinity Biosciences Business Overview
  76. 8.13.3 Affinity Biosciences EAAT2 Antibody Sales, Value and Gross Margin (2021-2026)
  77. 8.13.4 Affinity Biosciences EAAT2 Antibody Product Portfolio
  78. 8.13.5 Affinity Biosciences Recent Developments
  79. 8.14 Abcam
  80. 8.14.1 Abcam Company Information
  81. 8.14.2 Abcam Business Overview
  82. 8.14.3 Abcam EAAT2 Antibody Sales, Value and Gross Margin (2021-2026)
  83. 8.14.4 Abcam EAAT2 Antibody Product Portfolio
  84. 8.14.5 Abcam Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 EAAT2 Antibody Value Chain Analysis
  2. 9.1.1 EAAT2 Antibody Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 EAAT2 Antibody Sales Mode & Process
  6. 9.2 EAAT2 Antibody Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 EAAT2 Antibody Distributors
  9. 9.2.3 EAAT2 Antibody Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst